NCT04849416 2026-02-06A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)Eli Lilly and CompanyPhase 2 Completed87 enrolled 19 charts
NCT03277729 2026-01-05A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasFred Hutchinson Cancer CenterPhase 1/2 Active not recruiting53 enrolled 11 charts